Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-216-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20110216.11.3-216-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"I voted in favour of this report because we must take into account a concern which is getting higher and higher on the agenda of European citizens: the quality and safety of the medicinal products they are consuming. It is estimated that 1% of medicinal products currently sold to the European public through the legal supply chain are fake. In other parts of the world more than 30% of the medicines on sale can be fake. More and more innovative and life-saving drugs are counterfeit. It is well known that the Internet represents one of the main routes for falsified medicinal products to enter the European market. Medicinal products purchased over the Internet from sites that conceal their actual physical address are estimated to be falsified in more than 50 % of cases. People looking for cheaper medicines on the Internet are often hooked in by fraudsters selling counterfeit medicines with ingredients that pose a health risk. A lot of fake medicine is getting into the legal supply chain during repackaging. For too long we have lacked a proper response to dishonest repackagers and fraudsters rampant in the vastness of the Internet, while an ever increasing number of people buying medicines from untrustworthy websites have begun to put their health or even their lives at risk. I am pleased that penalties for counterfeiters have been set, along with measures to ensure a more stringent review. Registered pharmacies in countries where the sale of medicines over the Internet is permitted must obtain a special licence; their websites must carry the European logo and be included in the European database. Patients need to be absolutely sure that the medicines they consume really are the medicines they need to take. The protection of public health against falsified medicines should be the main focus."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples